CL vs. CPRX
Compare and contrast key facts about Colgate-Palmolive Company (CL) and Catalyst Pharmaceuticals, Inc. (CPRX).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: CL or CPRX.
Key characteristics
| CL | CPRX | |
|---|---|---|
| YTD Return | 15.52% | -11.42% |
| 1Y Return | 19.70% | -5.52% |
| 3Y Return (Ann) | 7.61% | 48.00% |
| 5Y Return (Ann) | 7.55% | 21.15% |
| 10Y Return (Ann) | 5.55% | 22.21% |
| Sharpe Ratio | 1.51 | -0.15 |
| Daily Std Dev | 14.32% | 48.46% |
| Max Drawdown | -67.62% | -94.25% |
| Current Drawdown | 0.00% | -29.26% |
Fundamentals
| CL | CPRX | |
|---|---|---|
| Market Cap | $71.62B | $1.79B |
| EPS | $2.77 | $0.63 |
| PE Ratio | 31.45 | 24.02 |
| PEG Ratio | 2.15 | 0.00 |
| Revenue (TTM) | $19.46B | $398.20M |
| Gross Profit (TTM) | $10.25B | $160.02M |
| EBITDA (TTM) | $4.51B | $119.69M |
Correlation
The correlation between CL and CPRX is 0.08, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Performance
CL vs. CPRX - Performance Comparison
In the year-to-date period, CL achieves a 15.52% return, which is significantly higher than CPRX's -11.42% return. Over the past 10 years, CL has underperformed CPRX with an annualized return of 5.55%, while CPRX has yielded a comparatively higher 22.21% annualized return. The chart below displays the growth of a $10,000 investment in both assets, with all prices adjusted for splits and dividends.
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
CL vs. CPRX - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Colgate-Palmolive Company (CL) and Catalyst Pharmaceuticals, Inc. (CPRX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
CL vs. CPRX - Dividend Comparison
CL's dividend yield for the trailing twelve months is around 2.13%, while CPRX has not paid dividends to shareholders.
| TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
CL Colgate-Palmolive Company | 2.13% | 2.40% | 2.36% | 2.10% | 2.05% | 2.48% | 2.79% | 2.11% | 2.37% | 2.25% | 2.05% | 2.04% |
CPRX Catalyst Pharmaceuticals, Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Drawdowns
CL vs. CPRX - Drawdown Comparison
The maximum CL drawdown since its inception was -67.62%, smaller than the maximum CPRX drawdown of -94.25%. Use the drawdown chart below to compare losses from any high point for CL and CPRX. For additional features, visit the drawdowns tool.
Volatility
CL vs. CPRX - Volatility Comparison
The current volatility for Colgate-Palmolive Company (CL) is 3.68%, while Catalyst Pharmaceuticals, Inc. (CPRX) has a volatility of 10.09%. This indicates that CL experiences smaller price fluctuations and is considered to be less risky than CPRX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Financials
CL vs. CPRX - Financials Comparison
This section allows you to compare key financial metrics between Colgate-Palmolive Company and Catalyst Pharmaceuticals, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities